Diabetic cardiomyopathy: where we are and where we are going
Wang-Soo Lee, Jaetaek Kim
Korean J Intern Med. 2017;32(3):404-421.   Published online 2017 Apr 18     DOI: https://doi.org/10.3904/kjim.2016.208
Citations to this article as recorded by Crossref logo
Exercise protects against diabetic cardiomyopathy by the inhibition of the endoplasmic reticulum stress pathway in rats
Wang Chengji, Fan Xianjin
Journal of Cellular Physiology.2019; 234(2): 1682.     CrossRef
Effect of Exercise Intervention on Cardiac Function in Type 2 Diabetes Mellitus: A Systematic Review
Maxim Verboven, Lisa Van Ryckeghem, Jamal Belkhouribchia, Paul Dendale, Bert O. Eijnde, Dominique Hansen, Virginie Bito
Sports Medicine.2019; 49(2): 255.     CrossRef
Pathophysiological mechanisms of diabetic cardiomyopathy and the therapeutic potential of epigallocatechin-3-gallate
Amir M. Al Hroob, Mohammad H. Abukhalil, Omnia E. Hussein, Ayman M. Mahmoud
Biomedicine & Pharmacotherapy.2019; 109: 2155.     CrossRef
Molecular Mechanisms Responsible for Diastolic Dysfunction in Diabetes Mellitus Patients
Jovana Nikolajević Starčević, Miodrag Janić, Mišo Šabovič
International Journal of Molecular Sciences.2019; 20(5): 1197.     CrossRef
Heart Failure: Complications of Type 2 Diabetes
Sang-Hoon Seol
The Journal of Korean Diabetes.2019; 20(1): 1.     CrossRef
Reactive Carbonyl Species: Diabetic Complication in the Heart and Lungs
Cheng-ju Tian, Zhong Zhen
Trends in Endocrinology & Metabolism.2019; 30(8): 546.     CrossRef
Chemical Structures and Pharmacological Profiles of Ginseng Saponins
Ze-Yu Shi, Jin-Zhang Zeng, Alice Sze Tsai Wong
Molecules.2019; 24(13): 2443.     CrossRef
Left ventricular diastolic dysfunction in diabetes mellitus and the therapeutic role of exercise training
Adriana Albu, Ioana Para, Constantin MUNTEANU
Balneo Research Journal.2019; 10(10.2): 145.     CrossRef
Diabetic cardiomyopathy: Pathophysiology, theories and evidence to date
Lavanya Athithan, Gaurav S Gulsin, Gerald P McCann, Eylem Levelt
World Journal of Diabetes.2019; 10(10): 490.     CrossRef
Role of CCR2 in the Development of Streptozotocin-Treated Diabetic Cardiomyopathy
Xin Tan, Lizhi Hu, Zhiping Shu, Long Chen, Xiangrao Li, Meng Du, Dan Sun, Xiaoxiang Mao, Shan Deng, Kai Huang, Fengxiao Zhang
Diabetes.2019; 68(11): 2063.     CrossRef
Inhibition of microRNA‐150‐5p alleviates cardiac inflammation and fibrosis via targeting Smad7 in high glucose‐treated cardiac fibroblasts
Hui Che, Yueqiu Wang, Yang Li, Jie Lv, Hui Li, Yining Liu, Ruixue Dong, Yongle Sun, Xiaodan Xu, Jie Zhao, Lihong Wang
Journal of Cellular Physiology.2019;[Epub]     CrossRef
Relationship between hemoglobin A1c and serum troponin in patients with diabetes and cardiovascular events
Stjepan Šimić, Tomo Svaguša, Ingrid Prkačin, Tomislav Bulum
Journal of Diabetes & Metabolic Disorders.2019; 18(2): 693.     CrossRef
Cardiovascular remodeling in patients with diabetic сardiomyopathy
A. S. Veklich, N. A. Koziolova, P. G. Karavaev
Russian Journal of Cardiology.2019; (11): 42.     CrossRef
Hydrogen Sulfide Attenuates High Glucose-induced Myocardial Injury in Rat Cardiomyocytes by Suppressing Wnt/beta-catenin Pathway
Min Zhang, Mao Ye
Current Medical Science.2019; 39(6): 938.     CrossRef
Diabetic Cardiomyopathy: Five Major Questions with Simple Answers
Miguel Alejandro Rodriguez-Ramos
US Cardiology Review.2019; 13(1): 46.     CrossRef
Hyperglycemia-induced cardiac contractile dysfunction in the diabetic heart
Raphael M. Singh, Tahreem Waqar, Frank C. Howarth, Ernest Adeghate, Keshore Bidasee, Jaipaul Singh
Heart Failure Reviews.2018; 23(1): 37.     CrossRef
Cardiac autonomic neuropathy: Risk factors, diagnosis and treatment
Victoria A Serhiyenko, Alexandr A Serhiyenko
World Journal of Diabetes.2018; 9(1): 1.     CrossRef
Emerging Actors in Diabetic Cardiomyopathy: Heartbreaker Biomarkers or Therapeutic Targets?
Xavier Palomer, Javier Pizarro-Delgado, Manuel Vázquez-Carrera
Trends in Pharmacological Sciences.2018; 39(5): 452.     CrossRef
Past and Current Status of Adult Type 2 Diabetes Mellitus Management in Korea: A National Health Insurance Service Database Analysis
Seung-Hyun Ko, Kyungdo Han, Yong-ho Lee, Junghyun Noh, Cheol-Young Park, Dae-Jung Kim, Chang Hee Jung, Ki-Up Lee, Kyung-Soo Ko
Diabetes & Metabolism Journal.2018; 42(2): 93.     CrossRef
The Chinese Herb Yi-Qi-Huo-Xue Protects Cardiomyocyte Function in Diabetic Cardiomyopathy
Xiangsheng Wang, Jing Huang, Shengyi Wang, Qing Ni
Evidence-Based Complementary and Alternative Medicine.2018; 2018: 1.     CrossRef
Long noncoding RNAs: A new player in the prevention and treatment of diabetic cardiomyopathy?
Chao Ma, Huan Luo, Bing Liu, Feng Li, Carsten Tschöpe, Xianen Fa
Diabetes/Metabolism Research and Reviews.2018; 34(8): e3056.     CrossRef
Current status and strategies of long noncoding RNA research for diabetic cardiomyopathy
Tarun Pant, Anuradha Dhanasekaran, Juan Fang, Xiaowen Bai, Zeljko J. Bosnjak, Mingyu Liang, Zhi-Dong Ge
BMC Cardiovascular Disorders.2018;[Epub]     CrossRef
Diabetic Cardiomyopathy: Current and Future Therapies. Beyond Glycemic Control
Giulia Borghetti, Dirk von Lewinski, Deborah M. Eaton, Harald Sourij, Steven R. Houser, Markus Wallner
Frontiers in Physiology.2018;[Epub]     CrossRef